• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Factors that Influence Latency Before Delivery for PPROM Outpatients

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • At-home management of premature prelabor rupture of membranes (PPROM) under the right clinical circumstances has been shown to be safe, but data regarding factors impacting the latency period remain limited
  • Point et al. (Acta Obstetrica et Gynecologica Scandinavica, 2021) identified the risk factors associated with a shortened latency to delivery in women with PPROM managed as outpatients

METHODS:

  • Retrospective cohort study
  • Participants
    • All patients in home care after PPROM at 24 to 36 weeks from 2009 to 2018
  • Study design
    • Latency ratio: Calculated as the ratio of the real latency period to the expected latency period, expressed as a percentage
    • Expected latency: Number of days between the PPROM date and the target term
    • Real latency: Number of days between the PPROM date and delivery
  • Primary outcomes measures
    • Latency ratio for each patient
    • Risk factors associated with the latency ratio

RESULTS:

  • 234 patients with PPROM managed at home
  • Patient characteristics
    • Mean maternal age: 28.8 years
    • Nulliparous: 45% 
    • History of PPROM: 5%
    • History of prematurity: 10%
  • Latency
    • Mean theoretical latency after PPROM: 45.2 ± 21.3 days
    • Mean observed latency after PPROM: 35.5 ± 20.7 days
    • Latency ratio: 80%
  • Percentage of patients with length of homecare >7 days: 83.8%
  • A lower latency ratio was significantly associated with
    • Oligohydramnios (p<0.001)
    • Gestational age at PPROM (p=0.006)
    • Leukocyte count at PPROM >12 × 109/L (p=0.025)
    • C-reactive protein concentration >5 mg/L at 7 days after PPROM (p=0.046)
  • Median latency ratio for oligohydramnios
    • <32 weeks: ~40%
    • >32 weeks: 100%
  • Cervical length was not associated with a lower latency ratio | However, data missing in 114/234 patients

CONCLUSION:

  • Most patients with PPROM managed at home achieve a latency period greater than 7 days
  • The biggest risk factor for a shortened latency period is oligohydramnios
  • The authors state

Previous studies have shown that home-care management of PPROM lengthens the latency period. It seems important to identify the risk factors that can influence this latency

However, this ratio was lower in patients with oligohydramnios or inflammatory syndrome 

Learn More – Primary Sources:

Risk factors associated with shortened latency before delivery in outpatients managed for preterm prelabor rupture of membranes

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

What is the Best Course of Action Following PPROM Between 24 and 37 Weeks?
Can Azithromycin be Used as an Alternative to Erythromycin for PPROM?
Does Use of Progestogen Prolong Labor in PPROM Pregnancies?
Does a Weekly Dose of 17-OHPC Improve Outcomes in the Setting of Preterm Ruptured Membranes?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site